Skip to main content
Clinical Trials/ISRCTN55552928
ISRCTN55552928
Completed
未知

Combination therapy with rheumatoid arthritis (COBRA)-light study, an open randomised trial comparing a modified COBRA therapy with the COBRA therapy according to treatment strategies for rheumatoid arthritis (BeSt) in early rheumatoid arthritis

Vrije University Medical Centre (VUMC) (The Netherlands)0 sites160 target enrollmentMarch 31, 2008

Overview

Phase
未知
Intervention
Not specified
Conditions
Rheumatoid arthritis
Sponsor
Vrije University Medical Centre (VUMC) (The Netherlands)
Enrollment
160
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Registry
who.int
Start Date
March 31, 2008
End Date
January 1, 2012
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vrije University Medical Centre (VUMC) (The Netherlands)

Eligibility Criteria

Inclusion Criteria

  • 1\. Active RA according to American College of Rheumatology (ACR) criteria
  • 2\. Greater than six swollen joints or greater than six painful joints
  • 3\. Disease duration less than two years
  • 4\. Erythrocyte sedimentation rate (ESR) greater than 28 mm
  • 5\. Visual analogue scale (VAS) greater than 20
  • 6\. Age greater than 18 years, either sex

Exclusion Criteria

  • 1\. Prior treatment DMARDs (except hydroxychloroquine)
  • 2\. Insulin\-dependent diabetes mellitus
  • 3\. Uncontrollable non\-insulin dependent diabetes mellitus
  • 4\. Heart failure New York Heart Association (NYHA) class 3 \- 4
  • 5\. Uncontrollable hypertension
  • 6\. Alanine aminotransferase (ALT)/aspartate aminotransferase (AST) greater than three times normal values
  • 7\. Reduced renal function (serum creatinine greater than 15 mcmol)
  • 8\. Contra\-indications for methotrexate, sulphasalazine or prednisolone
  • 9\. Indications of probable tuberculosis

Outcomes

Primary Outcomes

Not specified

Similar Trials